Starting on:
Mar 24, 2021
Ending on:
Mar 25, 2021
Moderator(s):
Venue:
THE KAREN HOSPITAL
Max Credits:
3 Points
Provider:
Karen Hospital
Claim Points
Mar 24, 2021
Ending on:
Mar 25, 2021
Moderator(s):
THE KAREN HOSPITAL
Max Credits:
3 Points
Provider:
Karen Hospital
Claim Points
DOCTOR'S CME - 25/03/2021
Starting on:
Mar 24, 2021 8:00 AM
Mar 24, 2021 8:00 AM
Ending on:
Mar 25, 2021 9:00 AM
Mar 25, 2021 9:00 AM
Venue:
THE KAREN HOSPITAL
THE KAREN HOSPITAL
Description
Helicobacter pylori, commonly called H. pylori, is a common type of bacteria that grows in the digestive tract and has a tendency to attack the stomach lining. It infects the stomachs of roughly 60 percentTrusted Source of the worldâ??s adult population. H. pylori infections are usually harmless, but theyâ??re responsible for the majority of ulcers in the stomach and small intestine.
Objectives
Recognize differences between ulcers induced by Helicobacter pylori, nonsteroidal anti-inflammatory drugs (NSAIDs), and stress-related mucosal damage (SRMD) in terms of risk factors, pathogenesis, signs and symptoms, clinical course, and prognosis.
Identify desired therapeutic outcomes for patients with H. pyloriâ??associated ulcers and NSAID-induced ulcers.
Identify factors that guide selection of an H. pylori eradication regimen and improve adherence with these regimens.
Determine the appropriate management for a patient taking a nonselective NSAID who is at high risk for ulcer-related gastrointestinal (GI) complications (eg, GI bleed) or who develops an ulcer.
Presenters
-
Dr.
LANCE MAYABI
MEDICAL OFFICER
THE KAREN HOSPITAL